J. Hernando Cubero

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

M. Marazuela, A. Lamarca, J. Valle, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Desmoid-Type Fibromatosis: Who, When, and How to Treat

J. Hernando Cubero, J. Martínez Trufero, I. Pajares Bernad, 2017, Current Treatment Options in Oncology.

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art.

J. Hernando Cubero, Á. Artal Cortés, Lourdes Calera Urquizu, 2015, Translational lung cancer research.

Adenosquamous Cell Carcinoma of the Rectum in a Girl: First Case Reported and Review of the Literature

J. Hernando Cubero, V. Alonso Orduña, N. Á. García, 2015, Journal of pediatric hematology/oncology.

Drug Development in Neuroendocrine Tumors: What Is on the Horizon?

J. Capdevila, J. Hernando Cubero, A. Garcia-Alvarez, 2021, Current Treatment Options in Oncology.

Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.

C. Font, F. Sánchez Lasheras, E. Castañón, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.